Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis

Kristian Reich; Siegfried Segaert; Peter Van de Kerkhof; Cis Durian; Marie Pierre Boussuge; Laurence Paolozzi; Joseph Wajdula; Robert Boggs

doi:10.1159/000237871

Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis

Dermatology ◽

10.1159/000237871 ◽

2009 ◽

Vol 219 (3) ◽

pp. 239-249 ◽

Cited By ~ 29

Author(s):

Kristian Reich ◽

Siegfried Segaert ◽

Peter Van de Kerkhof ◽

Cis Durian ◽

Marie Pierre Boussuge ◽

...

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Weekly Administration ◽

Severe Plaque Psoriasis ◽

Patient Reported

Download Full-text

Once-Weekly Administration of Etanercept 50mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/j.yder.2011.02.068 ◽

2011 ◽

Vol 2011 ◽

pp. 118-119

Author(s):

M. Lebwohl

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Weekly Administration ◽

Severe Plaque Psoriasis ◽

Patient Reported

Download Full-text

Patient‐reported outcomes with risankizumab versus fumaric acid esters in systemic therapy‐naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17109 ◽

2021 ◽

Author(s):

D Thaçi ◽

AM Soliman ◽

K Eyerich ◽

A Pinter ◽

M Sebastian ◽

...

Keyword(s):

Clinical Trial ◽

Fumaric Acid ◽

Plaque Psoriasis ◽

Systemic Therapy ◽

Patient Reported Outcomes ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Patient Reported ◽

Acid Esters

Download Full-text

Comparison of patient reported outcomes by biologic treatment use in patients with moderate to severe plaque psoriasis: Results from a compiled dataset of National Psoriasis Foundation panel surveys

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2012.12.807 ◽

2013 ◽

Vol 68 (4) ◽

pp. AB195

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Biologic Treatment ◽

Panel Surveys ◽

Severe Plaque Psoriasis ◽

Patient Reported ◽

National Psoriasis Foundation ◽

Treatment Use

Download Full-text

Impact of efalizumab on patient-reported outcomes in patients with moderate to severe plaque psoriasis: pooled results from three randomized phase III trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.549 ◽

2004 ◽

Vol 50 (3) ◽

pp. P156

Author(s):

Alan Menter ◽

Tiffani Hamilton ◽

Ivor Caro ◽

Amy Chen-Rundle

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Severe Plaque Psoriasis ◽

Patient Reported ◽

Phase Iii Trials

Download Full-text

Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2011.04394.x ◽

2011 ◽

Vol 27 (1) ◽

pp. 125-128 ◽

Cited By ~ 18

Author(s):

S. Tyring ◽

J. Bagel ◽

C. Lynde ◽

P. Klekotka ◽

E.H.Z. Thompson ◽

...

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Plaque Psoriasis ◽

Patient Reported

Download Full-text

Evaluation of Patient-Reported Outcomes with Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.4910 ◽

2020 ◽

Vol 19 (4) ◽

pp. 378-383

Author(s):

Jerry Bagel ◽

Bradley Stolshek ◽

Yue Yang ◽

Gregory Kricorian ◽

Leon Kircik

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Severe Plaque Psoriasis ◽

Patient Reported

Download Full-text

Improvements in patient-reported outcomes (PROs) among moderate to severe plaque psoriasis patients treated with brodalumab: Results from AMAGINE-1

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.02.994 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB256

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Severe Plaque Psoriasis ◽

Patient Reported

Download Full-text

Faculty Opinions recommendation of Patient-reported Outcomes and Clinical Response in Patients with Moderate-to-severe Plaque Psoriasis Treated with Tonsillectomy: A Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726937387.793525366 ◽

2016 ◽

Author(s):

Joel Gelfand ◽

Megan Noe

Keyword(s):

Randomized Controlled Trial ◽

Clinical Response ◽

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Severe Plaque Psoriasis ◽

Randomized Controlled ◽

Patient Reported

Download Full-text

Evaluation of optimal psoriasis assessment tool incorporating both clinical measures and patient-reported outcomes for the treatment of moderate-to-severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.764 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB208

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Assessment Tool ◽

Severe Plaque Psoriasis ◽

Patient Reported ◽

Clinical Measures

Download Full-text

541 Evaluation of optimal psoriasis assessment tool (OPAT) incorporating both clinical and patient-reported outcomes for treatment of moderate-to-severe plaque psoriasis

Journal of Investigative Dermatology ◽

10.1016/j.jid.2019.03.617 ◽

2019 ◽

Vol 139 (5) ◽

pp. S93

Author(s):

C. Leonardi ◽

K. See ◽

R. Burge ◽

G. Gallo ◽

M. McKean-Matthews ◽

...

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Assessment Tool ◽

Severe Plaque Psoriasis ◽

Patient Reported

Download Full-text